Picture of Multiqure SA logo

MQR — Multiqure SA News Story

0.000.00%
pl flag iconLast trade - 00:00
IndustrialsHighly SpeculativeSmall CapSucker Stock

Brief: Pure Biologics Gets Approval To Obtain Research Material

March 20 (Reuters) - Pure Biologics SA  PUR1.WA :
    * SAYS GETS APPROVAL FROM BIOETHICAL COMMISSION TO OBTAIN
RESEARCH
MATERIAL FROM PATIENTS WITH  NMO DISEASE
    * OBTAINING RESEARCH MATERIAL IS PART OF APTAPHERESIS
(PB002)
PROJECT TO BE CONDUCTED  IN 2018-2021
    * APPROVAL OF COMMISSION GIVES OPPORTUNITY FOR CO TO USE
OBTAINED
MATERIAL IN FURTHER PHASES OF PROJECT

Source text for Eikon:  ID:nEM8Yp3cTa 
Further company coverage:  PUR1.WA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48587720920;))

Recent news on Multiqure SA

See all news